Study: High-dose losartan doesn't raise death risk in heart patients

04/11/2012 | PhysiciansBriefing.com

A Danish study of more than 6,000 heart failure patients found that those who take a high dose of losartan have the same risk of dying as those taking a high dose of candesartan. The risk of death, however, is higher among heart failure patients who take low- or medium-dose losartan. The findings appear in the Journal of the American Medical Association.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX